LI
LSB INDUSTRIES, INC. (LXU)·Q3 2025 Earnings Summary
Executive Summary
- Q3 2025 delivered a clear inflection: revenue rose to $155.4M, GAAP diluted EPS to $0.10, and Adjusted EBITDA to $40.1M, with both price and volume tailwinds and no planned turnarounds; Street revenue and EPS were beaten, while EBITDA underperformed on a non-adjusted SPGI basis .
- S&P Global consensus indicated LXU beat Q3 revenue ($155.4M vs $138.3M*) and Primary EPS ($0.152* actual vs $0.085* est.), but missed on EBITDA ($35.4M* vs $38.4M*); company-reported Adjusted EBITDA was $40.1M, reflecting non-GAAP adjustments .
- Management expects Q4 to be higher than prior-year on better pricing/production; Tampa ammonia settled at $650/mt for Nov, NOLA UAN averaging >$300/t early-Q4, with ~35% of natural gas costs now contractually passed through—improving earnings visibility .
- Narrative/catalysts: robust industrial demand (nitric acid, AN for mining), tight U.S. nitrogen supply, strengthening UAN, CCS (El Dorado) tracking for end-2026 start; management emphasized renewed free cash flow generation and net leverage ~2x as of Q3 .
Values with * are retrieved from S&P Global.
What Went Well and What Went Wrong
-
What Went Well
- Price and volume tailwinds across products; net sales +42% y/y with UAN revenue +103% and AN & Nitric Acid +20% as higher operating rates and absence of 2024 turnarounds lifted volumes .
- Adjusted EBITDA more than doubled y/y to $40.1M, driven by pricing and volume, despite higher gas and transition costs; management reiterated free cash flow resumption and ~2x net leverage .
- Strategic positioning: strong industrial markets—tariff-supported domestic MDI boosting nitric acid; mining demand robust on copper/gold; “We’re encouraged with our progress and remain confident…creating long-term value for shareholders” (CEO) .
-
What Went Wrong
- Non-adjusted EBITDA (SPGI) missed consensus ($35.4M* actual vs $38.4M* est.), reflecting higher natural gas and costs linked to the HDAN-to-AN solution transition (railcar and maintenance) .
- UAN production undershot internal expectations in Q3 (volumes ~134.6k tons vs ~151.8k in Q2); management expects normalization in Q4 .
- Input costs: average natural gas used in production was $3.08/MMBtu vs $2.17 y/y; cost headwinds persisted, though partial mitigation via ~35% gas cost pass-through in industrial mix .
Values with * are retrieved from S&P Global.
Financial Results
Consolidated P&L (GAAP) and Key Non-GAAP
Values with * are retrieved from S&P Global.
Notes: Q3 2025 diluted EPS (GAAP) $0.10; Street “Primary EPS” differs in definition and is shown in Estimates Context below .
YoY Comparison (Select Q3 Metrics)
Product Sales Mix (Revenue)
KPIs: Volumes, ASPs, Benchmarks, Input Costs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “The third quarter presented a strong market backdrop, and we delivered solid results with clear momentum… We’ve generated solid free cash flow so far this year… strengthening our balance sheet” — Mark Behrman, CEO .
- “Higher pricing and increased sales volumes were somewhat offset by higher natural gas and other costs… we are back to generating free cash flow… net leverage at approximately two times” — Cheryl Maguire, CFO .
- “Demand for ammonium nitrate for explosives is robust… MDI production… supported by tariffs and anti-dumping duties… nitric acid sales remained strong” — Damien Renwick, CCO .
- On CCS: “We continue to expect the technical review of our permit to be completed in the first quarter of next year… operations to then begin by the end of 2026… approximately $15 million in annual EBITDA” — CEO .
Q&A Highlights
- Ammonia market tightness and pricing flow-through: management cited supply disruptions (Middle East, Trinidad), delays in new U.S. capacity, and healthy fall ammonia application; Tampa index flows through to pricing; Q4 outlook benefits .
- UAN outlook into 2026: management “well sold forward,” expects tightness and healthy pricing into Q1–Q2, as Chinese urea exports likely remain constrained; producers comfortable on inventory .
- Cost/mix impacts from HDAN transition: higher railcar/maintenance costs hit Q3; expect AN solution/nitric acid volumes “in line” with Q3; UAN volumes likely higher in Q4 .
- Contracting and margin power: stronger industrial demand and supportive nitrogen pricing aid renewals; impact depends on expiries but environment supports maintaining/increasing prices .
- Growth options: evaluating a second urea expansion (potential DEF entry) and an El Dorado ammonia expansion (~100k tons); would consider offtake backstops for larger expansions; CCS monetization via product premiums and environmental attributes .
Estimates Context
-
Q3 2025 vs S&P Global consensus: Revenue beat and EPS beat; EBITDA below consensus (non-adjusted).
- Revenue: $155.4M actual vs $138.3M est. — Beat* .
- Primary EPS (SPGI): $0.152* actual vs $0.085* est. — Beat*. GAAP diluted EPS reported by company was $0.10 .
- EBITDA (SPGI): $35.4M* actual vs $38.4M* est. — Miss*. Company Adjusted EBITDA was $40.1M .
-
Forward consensus (SPGI):
- Q4 2025: Revenue $157.7M*, Primary EPS $0.124*;
- FY 2025: Revenue $603.2M*, Primary EPS $0.367*;
- FY 2026: Revenue $581.1M*, Primary EPS $0.436*.
Values with * are retrieved from S&P Global.
Estimates and Actuals Table (SPGI)
Values with * are retrieved from S&P Global.
Key Takeaways for Investors
- Mix/price tailwinds plus higher run-rates delivered a revenue/EPS beat; non-adjusted EBITDA under-shot Street, but company Adjusted EBITDA was strong—expect investors to focus on cash generation and margin visibility from industrial pass-through .
- Macro setup looks favorable into Q4–H1’26: Tampa ammonia rising, UAN pricing firm, tight U.S. supply, robust mining and MDI-driven nitric acid demand—supportive for pricing and utilization .
- Transition from HDAN to AN solution is complete; near-term cost noise should fade, with benefits accruing via contract structures and pass-throughs (~35% gas exposure hedged via pricing) .
- Balance sheet and FCF improving: ~$36M FCF in Q3 and ~2x net leverage enhances optionality for reliability capex and selective growth (urea/DEF, El Dorado ammonia debottleneck) .
- CCS (El Dorado) remains a 2026–2027 earnings lever (~$15M EBITDA run-rate), with multiple monetization avenues (premium products, environmental attributes) .
- Watch list: Q4 execution on UAN volumes, gas cost trend into winter, any normalization in ammonia/UAN prices, and timing/progress on the EPA Class VI permit for CCS .
- Setup for estimate revisions: likely upward bias to revenue/EPS near term given pricing and volumes; EBITDA modeling should distinguish company Adjusted EBITDA vs SPGI EBITDA and reflect pass-through dynamics .
Appendix: Additional Data (Company-Reported)
- Product sales YoY (Q3 2025 vs Q3 2024): UAN +103%, Ammonia +30%, AN & Nitric Acid +20% .
- Key Q3 volumes: 380.6k total tons (AN & Nitric 159.7k; UAN 134.6k; Ammonia 86.3k) vs 291.1k in Q3’24 .
- Average selling prices: UAN $333/t (+50% y/y), Ammonia $400/t (+3% y/y), AN & Nitric Acid $307/t (flat) .
- Gas inputs: Avg used $3.08/MMBtu vs $2.17 y/y .
References:
- Q3 2025 8‑K/Press Release and financials .
- Standalone press release (same metrics presentation) .
- Q2 2025 press release for prior-quarter comps .
- Q1 2025 press release for multi-quarter context .
- Q3 2025 earnings call transcript for commentary and outlook .
Values with * are retrieved from S&P Global.